Targeted Delivery of Mesenchymal Stem Cell-Derived Bioinspired Exosome-Mimetic Nanovesicles with Platelet Membrane Fusion for Atherosclerotic Treatment
Yu Jiang,Miao Yu,Zhi-Feng Song,Zhi-Yao Wei,Ji Huang,Hai-Yan Qian
DOI: https://doi.org/10.2147/ijn.s452824
IF: 7.033
2024-03-14
International Journal of Nanomedicine
Abstract:Yu Jiang, 1, &ast Miao Yu, 1, &ast Zhi-Feng Song, 1, &ast Zhi-Yao Wei, 1 Ji Huang, 2 Hai-Yan Qian 1 1 Center for Coronary Heart Disease, Department of Cardiology, Fu Wai Hospital, National Center for Cardiovascular Diseases of China, State Key Laboratory of Cardiovascular Disease, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China; 2 Center for Coronary Artery Disease, Division of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart, Lung, and Blood Vessel Diseases, National Clinical Research Center for Cardiovascular Diseases, Beijing, People's Republic of China &astThese authors contributed equally to this work Correspondence: Ji Huang, Center for Coronary Artery Disease, Division of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart, Lung, and Blood Vessel Diseases, National Clinical Research Center for Cardiovascular Diseases, Beijing, 100029, People's Republic of China, Email Hai-Yan Qian, Center for Coronary Heart Disease, Department of Cardiology, Fu Wai Hospital, National Center for Cardiovascular Diseases of China, State Key Laboratory of Cardiovascular Disease, Chinese Academy of Medical Sciences and Peking Union Medical College, 167 Beilishi Road, Beijing, 100037, People's Republic of China, Email Purpose: Accumulating evidence indicates that mesenchymal stem cells (MSCs)-derived exosomes hold significant potential for the treatment of atherosclerosis. However, large-scale production and organ-specific targeting of exosomes are still challenges for further clinical applications. This study aims to explore the targeted efficiency and therapeutic potential of biomimetic platelet membrane-coated exosome-mimetic nanovesicles (P-ENVs) in atherosclerosis. Methods: To produce exosome-mimetic nanovesicles (ENVs), MSCs were successively extruded through polycarbonate porous membranes. P-ENVs were engineered by fusing MSC-derived ENVs with platelet membranes and characterized using transmission electron microscopy (TEM), nanoparticle tracking analysis (NTA), and Western blot. The stability and safety of P-ENVs were also assessed. The targeted efficacy of P-ENVs was evaluated using an in vivo imaging system (IVIS) spectrum imaging system and immunofluorescence. Histological analyses, Oil Red O (ORO) staining, and Western blot were used to investigate the anti-atherosclerotic effectiveness of P-ENVs. Results: Both ENVs and P-ENVs exhibited similar characteristics to exosomes. Subsequent miRNA sequencing of P-ENVs revealed their potential to mitigate atherosclerosis by influencing biological processes related to cholesterol metabolism. In an ApoE −/− mice model, the intravenous administration of P-ENVs exhibited enhanced targeting of atherosclerotic plaques, resulting in a significant reduction in lipid deposition and necrotic core area. Our in vitro experiments showed that P-ENVs promoted cholesterol efflux and reduced total cholesterol content in foam cells. Further analysis revealed that P-ENVs attenuated intracellular cholesterol accumulation by upregulating the expression of the critical cholesterol transporters ABCA1 and ABCG1. Conclusion: This study highlighted the potential of P-ENVs as a novel nano-drug delivery platform for enhancing drug delivery efficiency while concurrently mitigating adverse reactions in atherosclerotic therapy. Keywords: exosome-mimetic nanovesicles, platelet membrane-coated nanovesicles, biomimicry, targeted delivery, atherosclerosis Atherosclerosis is a chronic vascular disease characterized by the accumulation of lipid plaque within the arterial intima, gradually leading to arterial stenosis or occlusion. 1,2 As a hallmark of atherosclerotic lesions, foam cells play a pivotal role in the pathogenesis of atherosclerosis. Their aberrant lipid uptake, cholesterol esterification, and cholesterol efflux precipitate the occurrence and progression of atherosclerosis. 3 Despite considerable progress in conventional treatments for atherosclerosis, there remains an imperative to develop more precise and effective therapeutic strategies. Recently, the rapid advancements in nanotechnology and biomedicine have brought nanoparticles as a promising direction for improving atherosclerotic treatment. 4 A primary objective of nanotherapy is to address the solubility problems of developed drugs, thus improving their therapeutic efficacy. 5,6 Currently, the principal nanoparticles being explored for atherosclerotic treatment include natural nanoparticles such as extracellular vesicles (EVs) na -Abstract Truncated-
pharmacology & pharmacy,nanoscience & nanotechnology